Hawaii Biotech
Chemicals & Related Products · Hawaii, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Iwilei Rd Ste 204, Honolulu, Hawaii,...Phone Number
(808) 486-5333Website
www.hibiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Hawaii Biotech
Hawaii Biotech Inc. specializes in developing vaccines and medical countermeasures for emerging and re-emerging infectious diseases, including treatments for Anthrax and botulism. The company utilizes a recombinant subunit protein platform to produce high-quality proteins that maintain their native-like structure, outperforming traditional vaccine methods. Their innovative semi-synthetic adjuvant, GPI-0100, is designed to elicit broad immune responses for both vaccines and therapeutics. Target clients include healthcare providers and organizations focused on infectious disease prevention and treatment.Explore more
Hawaii Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hawaii Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Hawaii Biotech is spiking on competitors!
Click to see if Hawaii Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Hawaii Biotech
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Hawaii Biotech has new funding data
Product Launch: Get notified when Hawaii Biotech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Hawaii Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Hawaii Biotech has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Hawaii Biotech recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Hawaii Biotech
Compare insights from companies similar to Hawaii Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Hawaii Biotech
<$5M
11-50
Private
$50.4M
1982
RS
Richard ShermanVice President, Business Development & Director & General Counsel
Company Profile Activity
Activity Insights
Hawaii Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hawaii Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hawaii Biotech.
Hawaii Biotech financials insights
Gather financial insights about Hawaii Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1982
Unspecified
$50M
2020
Debt
$350K
Hawaii Biotech Tech Stack
A closer look at the technologies used by Hawaii Biotech
Most Recent Scoops
Funding
Project
Award, Spending/Investment, Product Development
Funding
Project
received an award of $203,485 on May 2, 2023 by HHS NIH with an award end date of April 30, 2025. This award will support efforts focused on identifying and developing novel TLR4 agonists as vaccine adjuvants to enhance immunogenicity and safety, aiming to improve pandemic preparedness through more effective and scalable vaccine solutions..
Bioengineering, Pharmaceuticals, Clinical Operations, Operations
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Left Company
Executive Move
Left Company
Promotion
Executive Move
Promotion
Hawaii Biotech News & Media
Soligenix Announces Publication Demonstrating Thermostabilization of Filovirus Vaccine Antigens
PRINCETON, N.J., Sept. 15, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publication of...Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform
PRINCETON, N.J., Feb. 27, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ongoing...Soligenix Announces Conference Presentations Demonstrating Formulations of Single and Multivalent Ebola Subunit Vaccines
PRINCETON, N.J., July 31, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that two posters...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hawaii Biotech
Sign Up For FreeTo access detailed company insights
Hawaii Biotech Inc. specializes in developing vaccines and medical countermeasures for emerging and re-emerging infectious diseases, including treatments for Anthrax and botulism. The company utilizes a recombinant subunit protein platform to produce high-quality proteins that maintain their native-like structure, outperforming traditional vaccine... Read More
